Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.

Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
复制标题

用于疾病建模和药物测试的组织芯片和微生理系统。

DOI:
10.3390/mi12020139
复制
发表时间:
2021-01-28
期刊:
影响因子:
3.4
通讯作者:
Sethu P
Sethu P
中科院分区:
工程技术3区
文献类型:
--
作者:
Donoghue L;Nguyen KT;Graham C;Sethu P

文献摘要

参考文献

被引文献

相似文献

组织芯片(TCS)和微生理系统(MPSS)结合了人类细胞,是建立疾病模型和筛选药物的新平台,并提供了传统动物研究的替代方案。本文重点介绍了TCS和MPSS的基本定义,考察了四种主要的器官/组织,确定了组织和功能的关键参数(组织结构、血流和物理应力),综述了目前重建组织的微流体方法,并讨论了这些技术目前的不足和未来的开发和应用方向。强调的器官是那些参与药物代谢或排泄的器官(肝脏和肾脏系统)和对药物毒性敏感的器官(心血管系统)。本文分别研究了每个器官的微流控/微制造方法,并确定了TCS的具体例子。这篇综述将为理解、设计和构建可能整合到MPS中的新型TC提供一个很好的起点。
Tissue chips (TCs) and microphysiological systems (MPSs) that incorporate human cells are novel platforms to model disease and screen drugs and provide an alternative to traditional animal studies. This review highlights the basic definitions of TCs and MPSs, examines four major organs/tissues, identifies critical parameters for organization and function (tissue organization, blood flow, and physical stresses), reviews current microfluidic approaches to recreate tissues, and discusses current shortcomings and future directions for the development and application of these technologies. The organs emphasized are those involved in the metabolism or excretion of drugs (hepatic and renal systems) and organs sensitive to drug toxicity (cardiovascular system). This article examines the microfluidic/microfabrication approaches for each organ individually and identifies specific examples of TCs. This review will provide an excellent starting point for understanding, designing, and constructing novel TCs for possible integration within MPS.
DOI: 10.1039/c5lc00507h
发表时间: 2015-09-07
期刊: Lab on a chip
影响因子: 6.1
作者:
Alonzo LF;Moya ML;Shirure VS;George SC
通讯作者: George SC
DOI: 10.1093/toxsci/kfx289
发表时间: 2018-04-01
期刊: Toxicological sciences : an official journal of the Society of Toxicology
影响因子: --
作者:
Bell CC;Dankers ACA;Lauschke VM;Sison-Young R;Jenkins R;Rowe C;Goldring CE;Park K;Regan SL;Walker T;Schofield C;Baze A;Foster AJ;Williams DP;van de Ven AWM;Jacobs F;Houdt JV;Lähteenmäki T;Snoeys J;Juhila S;Richert L;Ingelman-Sundberg M
通讯作者: Ingelman-Sundberg M
DOI: 10.1007/s11892-020-01357-1
发表时间: 2020-11-18
影响因子: 4.2
作者:
Abadpour S;Aizenshtadt A;Olsen PA;Shoji K;Wilson SR;Krauss S;Scholz H
通讯作者: Scholz H
DOI: 10.1016/j.pbiomolbio.2014.07.001
发表时间: 2014-08
影响因子: 3.8
作者:
Ambrosi CM;Klimas A;Yu J;Entcheva E
通讯作者: Entcheva E
DOI: 10.1152/ajpheart.00514.2007
发表时间: 2007-09-01
影响因子: 4.8
作者:
Banerjee, Indroneal;Fuseler, John W.;Baudino, Troy A.
通讯作者: Baudino, Troy A.